Utility and Applications of Orthotopic Models of Human Non‐Small Cell Lung Cancer (NSCLC) for the Evaluation of Novel and Emerging Cancer Therapeutics
Authors:
Open Access
- 1 October 2013
- journal article
- unit
- Published by Wiley in Current Protocols in Pharmacology
- Vol. 62 (1) , 14.27.1-14.27.17
Abstract
Lung cancer is a leading cause of cancer deaths worldwide. Despite advances in chemotherapy, radiation therapy, and surgery, lung cancer continues to have a low 5‐year survival rate, highlighting a dire need for more effective means of prevention, diagnosis, prognosis, and treatment. Mouse models that recapitulate the clinical features of advanced human lung cancer are critical for testing novel therapeutic approaches. This unit describes a highly reproducible, easy‐to‐establish orthotopic murine model of lung cancer, provides methods for in vivo imaging and monitoring of tumor growth, and discusses the usefulness of this model for translational lung cancer research and the development of therapeutic strategies. Curr. Protoc. Pharmacol. 62:14.27.1‐14.27.17. © 2013 by John Wiley & Sons, Inc.Keywords
This publication has 26 references indexed in Scilit:
- Selumetinib plus docetaxel for KRAS-mutant advanced non-small-cell lung cancer: a randomised, multicentre, placebo-controlled, phase 2 studyThe Lancet Oncology, 2013
- Matrix Metalloproteinase-10 Is Required for Lung Cancer Stem Cell Maintenance, Tumor Initiation and Metastatic PotentialPLOS ONE, 2012
- Combined MEK and VEGFR Inhibition in Orthotopic Human Lung Cancer Models Results in Enhanced Inhibition of Tumor Angiogenesis, Growth, and MetastasisClinical Cancer Research, 2012
- Bioluminescent Orthotopic Mouse Models of Human Localized Non-Small Cell Lung Cancer: Feasibility and Identification of Circulating Tumour CellsPLOS ONE, 2011
- Ect2 links the PKCι–Par6α complex to Rac1 activation and cellular transformationOncogene, 2009
- Cooperation of the Agonistic DR5 Antibody Apomab with Chemotherapy to Inhibit Orthotopic Lung Tumor Growth and Improve SurvivalClinical Cancer Research, 2008
- Matrix metalloproteinase-10 is a critical effector of protein kinase Cι-Par6α-mediated lung cancerOncogene, 2008
- Systemic Chemotherapy for Advanced Non-Small Cell Lung Cancer: Recent Advances and Future DirectionsThe Oncologist, 2008
- A Novel Small-Molecule Inhibitor of Protein Kinase Cι Blocks Transformed Growth of Non–Small-Cell Lung Cancer CellsCancer Research, 2006
- Complexes of Ras⋅GTP with Raf-1 and Mitogen-Activated Protein Kinase KinaseScience, 1993